The Technical Analyst
Select Language :
Annovis Bio Inc [ANVS]

Exchange: AMEX Industry: Biotechnology

Annovis Bio Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Annovis Bio Inc is listed at the  Exchange

-1.08% $11.90

America/New_York / 28 mar 2024 @ 16:00


Annovis Bio Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 127.27 mill
EPS: -4.84
P/E: -2.46
Earnings Date: Mar 31, 2024
SharesOutstanding: 10.69 mill
Avg Daily Volume: 0.289 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Sell
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.46 | sector: PE 12.30
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -2.46 | industry: PE -5.55
DISCOUNTED CASH FLOW VALUE
$3.48
(-70.78%) $-8.42
Date: 2024-03-29
Expected Trading Range (DAY)

$ 11.02 - 12.78

( +/- 7.42%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-11-20 White Mark K. Buy 1 990 Common Stock
2023-11-20 Mccarthy Reid Buy 0 Common Stock
2023-11-20 Hoffman Michael B Buy 163 880 Common Stock
2023-11-20 Maccecchini Maria-luisa Buy 40 970 Common Stock
2023-11-20 Hagopian Henry Iii Buy 820 Common Stock
INSIDER POWER
89.74
Last 98 transactions
Buy: 4 567 241 | Sell: 3 252 094

Forecast: 16:00 - $11.90

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $11.90
Forecast 2: 16:00 - $11.90
Forecast 3: 16:00 - $11.90
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $11.90 (-1.08% )
Volume 0.249 mill
Avg. Vol. 0.289 mill
% of Avg. Vol 86.23 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Annovis Bio Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Annovis Bio Inc

RSI

Intraday RSI14 chart for Annovis Bio Inc

Last 10 Buy & Sell Signals For ANVS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Annovis Bio Inc

ANVS

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Last 10 Buy Signals

Date Signal @
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12
DCRUSDMar 29 - 08:30$28.20
RBNUSDMar 29 - 08:301.670
GTUSDMar 29 - 08:30$9.91
BORAUSDMar 29 - 08:29$0.227

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.